Rarecells
PrivateLast Round
Series A
Dec 9, 2021
Total Funding Raised
$13M
Company Overview
Rarecells is a biotechnology company that develops a liquid biopsy system designed for the early-stage detection of cancer using circulating tumor cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rarecells Comparables
Compare Rarecells with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SmartCatch | 88% | |
| ScreenCell | 86% | |
| Cell Microsystems | 83% | |
Rarecells Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 9, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 9, 2025
New data from BioMolCTC Trial presented at lung cancer conference.
- Sep 9, 2025
Presented new data at the IASLC World Conference on Lung Cancer.
Rarecells Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rarecells's valuation, stock price, and market status.